Nicotinell Gum 2mg Mint (pack of 24)-Hyperdrug

Nicotinell 2mg gum is best suited for those who are light smokers, heavier smokers who are more likely to experience severe withdrawal symptoms should use Nicotinell 4mg gum. You've taken a positive step towards a smoke-free beginning, soft chewing Nicotinell gum comes in a range of unexpectedly bold flavours that are pleasant to chew throughout the day, Nicotinell can help you control the cravings that often occur as you try to achieve a smoke free life. Heavier smokers who are more likely to experience severe withdrawal symptoms should use Nicotinell 4mg gum. Nicotinell 2mg gum is best suited for those who are light smokers. Nicotinell helps to almost double your chances of quitting compared to willpower alone. Nicotinell chewing gum is a crispy coated, soft chewing gum with an unexpectedly bold taste. As you chew, it releases nicotine to help ease your physical cravings and reduce your desire to smoke. To get maximum effectiveness from Nicotinell gum it's critical you follow a "chew and park" method for at least 30 minutes. Chewing the gum for a couple of minutes only without parking it, doesn't allow the gum to help provide relief from cravings.

Product information leaflet:

http://emc.medicines.org.uk/medicine/20852/SPC/Nicotinell mint 2mg medicated chewing gum/

One piece of medicated chewing gum contains 2 mg nicotine (as 10 mg nicotine – polacrilin (1:4)).Medicated chewing gum. Each piece of coated chewing gum is off-white in colour and rectangular in shape. Nicotinell gum is indicated for the relief of nicotine withdrawal symptoms, as an aid to smoking cessation. Concurrent counselling/behavioural support is recommended as it is likely to increase the chances of a successful quit.

Adults and elderly Users should stop smoking completely during treatment with Nicotinell gum. One piece of Nicotinell gum to be chewed when the user feels the urge to smoke. Normally, 8-12 pieces per day can be used, up to a maximum of 25 pieces per day. The 2 mg chewing gum may not be well suited to smokers with a strong or very strong nicotine dependency. The 4 mg chewing gum is intended to be used by smokers with a strong or very strong nicotine dependency and those who have previously failed to stop smoking with the aid of nicotine replacement therapy. The optimal dosage form is selected according to the following table:

If an adverse event is noted when high dose forms are initiated, this should be replaced by the lower dosage form. The characteristics of chewing-gum as a pharmaceutical form are such that individually different nicotine levels can result in the blood. Therefore, dosage frequency should be adjusted according to individual requirements within the stated maximum limit. Directions for use: 1. One piece of gum should be chewed until the taste becomes strong. 2. The chewing gum should be rested between the gum and cheek. 3. When the taste fades, chewing should commence again. 4. The chewing routine should be repeated for 30 minutes. The treatment time is individual. Normally, treatment should continue for at least 3 months. After three months, the user should gradually cut down the number of pieces chewed each day until they have stopped using the product. Treatment should be discontinued when the dose has been reduced to 1-2 pieces of gum per day. Use of nicotine products like Nicotinell gum beyond 6 months is generally not recommended. Some ex-smokers may need treatment with the gum for longer to avoid returning to smoking. Patients who have been using oral nicotine replacement therapy beyond 9 months are advised to seek additional help and information from health care professionals. Nicotinell gum is sugar free. Adolescents (aged 12-18 years of age) The above recommendation can be used for adolescents aged between 12 and 18 years of age. As data are limited in this age group, medical advice should be obtained should it be found necessary to use the gum beyond 12 weeks. Concomitant use of acidic beverages such as coffee or soda may decrease the buccal absorption of nicotine. Acidic beverages should be avoided for 15 minutes prior to chewing the gum.

Any risks that may be associated with nicotine replacement therapy are substantially outweighed by the well established dangers of continued smoking. Precautions: Users should stop smoking completely during therapy with Nicotinell gum. They should be informed that if they continue to smoke while using the gums they may experience increased adverse effects due to the hazards of smoking, including cardiovascular effects. Cardiovascular disease In stable cardiovascular disease Nicotinell gum presents a lesser hazard than continuing to smoke. However dependant smokers currently hospitalised as a result of a recent myocardial infarction, severe disrythmia, or recent cerebrovascular accident who are considered to be haemodynamically unstable should be encouraged to stop smoking with non-pharmacological interventions. If this fails, Nicotinell gum may be considered but as data on safety in this patient group are limited, initiation should only be under medical supervision. Diabetes mellitus Patients with diabetes mellitus should be advised to monitor their blood sugar levels more closely than usual when nicotine replacement therapy is initiated as catecholamines released by nicotine can affect carbohydrate metabolism. Allergic reactions Angioedema and urticaria have been reported. Gastro-intestinal disease Swallowed nicotine may exacerbate symptoms in patients suffering from oesophagitis, gastritis, or peptic ulcers and oral nicotine replacement therapy preparations should be used with caution in these conditions. Ulcerative stomatitis have been reported. Renal and or hepatic impairment Should be used with caution in patients with moderate to severe hepatic impairment and/or severe renal impairment as the clearance of nicotine or its metabolites may be decreased with the potential for increased adverse effects. Danger in small children Doses of nicotine tolerated by adult and adolescent smokers can produce severe toxicity in small children that may be fatal. Products containing nicotine should not be left where they may be misused, handled or ingested by children. Nicotinell gum should be disposed of with care. Pheochromocytoma and uncontrolled hyperthyroidism Nicotinell gum should be used with caution in patients with uncontrolled hyperthyroidism or pheochromocytoma as nicotine causes the release of catecholamines. Transferred dependence Transferred dependence is rare and is both less harmful and easier to break than smoking dependence. Stopping smoking Polycyclic aromatic hydrocarbons in tobacco smoke induce the metabolism of drugs catalysed by CYP 1A2 (and possibly CYP 1A1). When a smoker stops, this may result in slower metabolism and a consequential rise in blood levels of drugs such as theophylline, tacrine, olanzapine and clozaprine. Other warnings If denture wearers experience difficulty in chewing the gum, it is recommended that they use a different pharmaceutical form of nicotine replacement therapy. Patients with rare hereditary problems of fructose intolerance should not take this medicine. Nicotinell 2mg gum contains sorbital (E420) 0.2g per gum, a source of 0.04g fructose. Calorific value 1.0 kcal/piece of gum. Nicotinell 2mg gum contains sodium 11.50 mg per piece of gum.